Journal of Cancer Therapy
Vol.5 No.14(2014), Paper ID 52047, 8
pages
DOI:10.4236/jct.2014.514139
Prognostic Value of Lymphocyte Vascular Density and E-Cadherin in Inflammatory Breast Cancer
Paul H. Levine, Heather J. Hoffman, Audra MacNeil, Salman Hashmi, Sherry X. Yang, Stephen Hewitt, Kenneth L. van Golen, Sandra M. Swain
Department of Epidemiology and Biostatistics, Milken Institute School of Public Health, The George Washington University, Washington DC, USA
Department of Epidemiology and Biostatistics, Milken Institute School of Public Health, The George Washington University, Washington DC, USA
Department of Epidemiology and Biostatistics, Milken Institute School of Public Health, The George Washington University, Washington DC, USA
Department of Epidemiology and Biostatistics, Milken Institute School of Public Health, The George Washington University, Washington DC, USA
National Clinical Target Validation Laboratory, Division of Cancer Treatment & Diagnosis, National Cancer Institute, Bethesda, USA
Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, USA
Department of Biological Sciences, Center for Translational Cancer Research, The University of Delaware, Newark, USA
Washington Cancer Institute, MedStar Washington Hospital Center, Washington DC, USA
Copyright © 2014 Paul H. Levine, Heather J. Hoffman, Audra MacNeil, Salman Hashmi, Sherry X. Yang, Stephen Hewitt, Kenneth L. van Golen, Sandra M. Swain et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Levine, P. , Hoffman, H. , MacNeil, A. , Hashmi, S. , Yang, S. , Hewitt, S. , Golen, K. and Swain, S. (2014) Prognostic Value of Lymphocyte Vascular Density and E-Cadherin in Inflammatory Breast Cancer.
Journal of Cancer Therapy,
5, 1380-1387. doi:
10.4236/jct.2014.514139.